Non-paraneoplastic cerebellar ataxia associated with voltage-gated calcium channel (VGCC) antibodies is a rare entity with only few cases reported in literature. We describe a 60 year-old man with subacute cerebellar ataxia and subclinical Lambert-Eaton myasthenic syndrome (LEMS) in whom VGCC antibodies were detected at high titer in serum and cerebrospinal fluid. Screening for underlying malignancies was negative. Intravenous immunoglobulin treatment led to the improvement of clinical picture and reduction of serum antibody titer over a 13-month follow-up period. We emphasize that VGCC antibodies should be included in the diagnostic work-up of patients with subacute cerebellar ataxia and that treatment with IVIG can improve the clinical picture and prevent disability. © 2013 Elsevier B.V. All rights reserved.

Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment / A. Rigamonti, G. LAURIA PINTER, L. Stanzani, V. Mantero, F. Andreetta, A. Salmaggi. - In: JOURNAL OF THE NEUROLOGICAL SCIENCES. - ISSN 0022-510X. - 336:1-2(2014 Jan 15), pp. 169-170. [10.1016/j.jns.2013.10.031]

Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment

G. LAURIA PINTER;
2014

Abstract

Non-paraneoplastic cerebellar ataxia associated with voltage-gated calcium channel (VGCC) antibodies is a rare entity with only few cases reported in literature. We describe a 60 year-old man with subacute cerebellar ataxia and subclinical Lambert-Eaton myasthenic syndrome (LEMS) in whom VGCC antibodies were detected at high titer in serum and cerebrospinal fluid. Screening for underlying malignancies was negative. Intravenous immunoglobulin treatment led to the improvement of clinical picture and reduction of serum antibody titer over a 13-month follow-up period. We emphasize that VGCC antibodies should be included in the diagnostic work-up of patients with subacute cerebellar ataxia and that treatment with IVIG can improve the clinical picture and prevent disability. © 2013 Elsevier B.V. All rights reserved.
antibodies; cerebellar ataxia; eaton-lambert myasthenic syndrome; immuno-mediated ataxia; intravenous immunoglobulin; voltage-gated calcium channels; autoantibodies; calcium channels; cerebellar ataxia; diagnosis, differential; humans; immunoglobulins, intravenous; lambert-eaton myasthenic syndrome; male; middle aged; treatment outcome; neurology; neurology (clinical)
Settore MED/26 - Neurologia
15-gen-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
VGCC ataxia_JNS2014.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 126.35 kB
Formato Adobe PDF
126.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/530260
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact